Dr. Gopal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Seattle Cancer Care Alliance (UW/FHCRC)
825 Eastlake Avenue East
Seattle, WA 98109Phone+1 206-606-1000
Summary
- Dr. Ajay Gopal is an oncologist in Seattle, WA and is affiliated with multiple hospitals in the area, including University of Washington Medical Center and Seattle Cancer Care Alliance. He received his medical degree from Emory University School of Medicine and has been in practice 24 years. He specializes in hematologic oncology and is experienced in hematologic oncology, Hodgkin’s lymphoma, non-Hodgkin’s Lymphoma, CLL, transplant, and cellular therapy.
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 1997 - 2000
- Duke University HospitalResidency, Internal Medicine, 1993 - 1996
- Emory University School of MedicineClass of 1993
Certifications & Licensure
- WA State Medical License 1997 - 2026
- NC State Medical License 1996 - 1998
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies Start of enrollment: 2003 Aug 01
- Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Start of enrollment: 1999 Feb 01
- Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Start of enrollment: 1999 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsCD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell m...Hongjie Wang, Theo Koob, Jonathan R Fromm, Ajay Gopal, Darrick Carter
Cancer Biology & Therapy. 2024-12-31 - Development and validation of predictive models of early immune effector cell-associated hematotoxicity (eIPMs).Emily C Liang, Jennifer J Huang, Andrew J Portuguese, Valentín Ortiz-Maldonado, Aya Albittar
Blood Advances. 2024-12-03 - Clinical Relevance of Intensive Laboratory Monitoring With Standard Venetoclax Ramp-Up for Chronic Lymphocytic Leukemia: A Real-World Experience.Ivan J Huang, Grace T Baek, Jonathan Cohen, Sirin Khajaviyan, Stephanie Louie
JCO Oncology Practice. 2024-11-18
Journal Articles
- Translating Anti-CD19 CAR T-cell Therapy into Clinical Practice for relapsed/refractory Diffuse Large B-cell LymphomaMazyar Shadman, Ajay K Gopal, Victor A Chow, Blood
Abstracts/Posters
- AG-636 for the Treatment of Adults with Advanced Lymphoma: Initiation of a Phase 1 Clinical StudyAjay K. Gopal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Relapsed or Refractory CLL after CD19-Specific CAR-T Therapy: Treatment Patterns and Clinical OutcomesAjay K. Gopal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Impact of Lab Abnormalities at the Time of Progression in Patients Receiving CD19-Specific CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell LymphomasAjay K. Gopal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Indolent Lymphomas: The Marathon Has a New Course61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Prolonged Lenalidomide Therapy in Multiple Myeloma Patients Does Not Impact Autologous PBSC Mobilization: A Single Center Retrospective Analysis2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Outcomes of Patients with Large B-Cell Lymphomas and Progressive Disease Following CD19-Specific CAR T-Cell TherapyClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Dr. Ajay Gopal Named Stephen H. Petersdorf Endowed Chair in Cancer Care at UW MedicineJanuary 26th, 2023
- DLBCL: PFS but No OS Benefit with Polatuzumab-Vedotin Add-OnDecember 17th, 2021
- Ibrutinib Add-on 'Almost Certainly' Saves Lives in DLBCLNovember 4th, 2021
- Join now to see all
Grant Support
- Radioimmunotherapy For LymphomaNational Cancer Institute2011
- Radiolabeled Antibody Therapy Of B-Cell LymphomaNational Cancer Institute2005–2009
- Proapoptotic Therapy For B-Cell NON Hodgkin'S LymphomaNational Cancer Institute2006–2007
- Optimizing Radioimmunotherapy For NON Hodgkin'S LymphomaNational Cancer Institute2000–2005
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: